<DOC>
	<DOCNO>NCT00026468</DOCNO>
	<brief_summary>RATIONALE : Exisulind may effective prevent development growth polyp patient familial adenomatous polyposis . PURPOSE : Randomized phase II/III trial determine effectiveness exisulind prevent development growth polyp patient familial adenomatous polyposis .</brief_summary>
	<brief_title>Exisulind Preventing Polyps Patients With Familial Adenomatous Polyposis</brief_title>
	<detailed_description>OBJECTIVES : - Determine ability exisulind inhibit growth development duodenal adenoma patient familial adenomatous polyposis . - Determine effect apoptosis polyp v mucosal tissue patient treat drug . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients randomize one two treatment arm . - Arm I : Patients receive oral exisulind 4 time daily . - Arm II : Patients receive oral placebo 4 time daily . Treatment continue 1 year . PROJECTED ACCRUAL : A total 100 patient ( 50 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Sulindac sulfone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow diagnosis : Diagnosis familial adenomatous polyposis Prior total subtotal colectomy Attenuated adenomatous polyposis coli May colon intact 1040 duodenal polyp second portion 10 cm distal papilla Vater PATIENT CHARACTERISTICS : Age : 18 80 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Hemoglobin least 10 g/dL Platelet count least 100,000/mm^3 No active hematologic disease Hepatic : AST ALT less 1.5 time upper limit normal ( ULN ) Alkaline phosphatase less 1.5 time ULN No active hepatic disease Renal : Creatinine le 1.5 mg/dL No active renal disease Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No active peptic ulcer disease No serious underlie medical psychiatric illness would preclude completion study limit survival No prisoner institutionalize patient No know allergy sulindac related compound No active internal malignancy within past 5 year No alcohol drug abuse within past 5 year PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics Other : No prior nonsteroidal antiinflammatory drug ( NSAIDs ) salicylates 10 day month past 3 month No concurrent NSAIDs ( e.g. , mesalamine , olsalazine , azodisalicylate , salsalate , sulfasalazine ) Aspirin cardiac reason allow ( 81 mg/day 325 mg twice/week )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
	<keyword>small intestine cancer</keyword>
</DOC>